Back to mobile site

Citi Reiterates Buy Rating on Eli Lilly (LLY)

December 20, 2024 8:43 AM EST Send to a Friend
Citi analyst Geoff Meacham reiterated a Buy rating and $1,250.00 price target on Eli Lilly (NYSE: LLY).The analyst comments "We ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login